AstraZeneca Pharma India has surged 10% to Rs 809 on NSE after reporting a net profit of Rs 1.52 crore for the quarter ended December 31, 2013 (Q3FY14). The pharmaceutical company had posted loss of Rs 17.70 crore in the same quarter last fiscal.
Total income from operations of the company grew by 13.3% at Rs 119 crore for the quarter against Rs 105 crore in the corresponding quarter of previous year, while total expenditure declined by 3.25% yoy at Rs 119 core.
The company has reported operating profit of Rs 2.97 crore against loss of Rs 15.37 crore during the recently concluded quarter.
The stock opened at Rs 757 and touched high of Rs 814 on the NSE. A combined around 91,000 shares changed hands on the counter till 0935 hours on the NSE and BSE.
Total income from operations of the company grew by 13.3% at Rs 119 crore for the quarter against Rs 105 crore in the corresponding quarter of previous year, while total expenditure declined by 3.25% yoy at Rs 119 core.
The company has reported operating profit of Rs 2.97 crore against loss of Rs 15.37 crore during the recently concluded quarter.
The stock opened at Rs 757 and touched high of Rs 814 on the NSE. A combined around 91,000 shares changed hands on the counter till 0935 hours on the NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%